Skip to content
Clinical Trial Events
BIO-Europe 2026

Talk Presenting Companies (Theatre B) track

Drug Delivery: Huonslab

Mon, Nov 9, 2026 · 2:00–2:15 PM CET Koelnmesse

About this session

Huonslab Co, Ltd., a subsidiary of Huons Global (KOSDAQ:084110), is a biotechnology company specializing in biologics and innovative drug delivery technologies. Founded in 2018, the company has developed HyDIFFUZE™, its proprietary recombinant human hyaluronidase (rHuPH20) platform, designed to enable the conversion of intravenous biologics into rapid subcutaneous formulations. Through scientific innovation and strategic global partnerships, Huonslab Co, Ltd. aims to improve patient convenience while expanding the accessibility of biologic therapies. Huonslab Highlights - Huonslab Co, Ltd.

Speaker